Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

Online First

December 16, 2020

Correspondence
Correspondence on ‘Jan Gösta Waldenström and rheumatology’
Free

Haralampos M Moutsopoulos

doi: 10.1136/annrheumdis-2020-219508

December 14, 2020

Correspondence
Correspondence on ‘Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities’
Free

Johan Rönnelid, Örjan Dahlström, Charlotte Dahle, Christopher Sjöwall

doi: 10.1136/annrheumdis-2020-219296
Correspondence response
Response to: ‘Correspondence on ‘Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities’’ by Ronnelid et al
Free

Sindhu R Johnson, Martin Aringer

doi: 10.1136/annrheumdis-2020-219314
Correspondence response
Response to: ‘Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19- associated cytokine storm syndrome: results of the CHIC study’’ by Calvo-Aranda et al

Sofia Ramiro, Rémy Mostard, Robert BM Landewé

doi: 10.1136/annrheumdis-2020-219534
Correspondence
Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study’
Free

Enrique Calvo-Aranda, Irene Cañamares-Orbis, Marta Novella-Navarro, Alvaro Martinez-Alcala, Maria del Carmen Ortega de la O, Ismael Escobar-Rodriguez, Fernando Manuel Sanchez-Aranda

doi: 10.1136/annrheumdis-2020-219479

December 11, 2020

Correspondence
Correspondence on ‘Risk of systemic lupus erythematosus after immune thrombocytopenia and autoimmune haemolytic anaemia: a nationwide French study’
Free

Julien Maquet, Margaux Lafaurie, Laurent Sailler, Maryse Lapeyre-Mestre, Guillaume Moulis

doi: 10.1136/annrheumdis-2020-219470
Correspondence response
Response to: ‘Correspondence on ‘Risk of systemic lupus erythematosus after immune thrombocytopenia and autoimmune haemolytic anaemia: a nationwide French study’’ by Maquet et al
Free

Xiao-Huan Chen, James Cheng Chung Wei, Han-You Mo, Hsin-Hua Chen

doi: 10.1136/annrheumdis-2020-219583

December 09, 2020

Correspondence
Correspondance on ‘Clinical characteristics and genetic analyses of 187 patients with undefined autoinflammatory diseases’
Free

Gonçalo Boleto, Carolla El Chamieh, Lucie Biard, Isabelle Koné-Paut, Veronique Hentgen, Guilaine Boursier, Guillaume Sarrabay, Patrice Cacoub, Isabelle Touitou, David Saadoun

doi: 10.1136/annrheumdis-2020-219566

December 04, 2020

Correspondence
Correspondence on: ‘EULAR definition of difficult-to-treat rheumatoid arthritis’
Free

Marta Novella-Navarro, Chamaida Plasencia-Rodríguez, Carolina Tornero, Victoria Navarro-Compán, José Luis Cabrera-Alarcón, Diana Peiteado, Laura Nuño, Irene Monjo, Karen Franco-Gómez, Alejandro Villalba, Alejandro Balsa

doi: 10.1136/annrheumdis-2020-219500
Correspondence response
Response to: ‘Correspondence on ‘EULAR definition of difficult-to-treat rheumatoid arthritis’’ by Novella-Navarro et al
Free

Nadia M T Roodenrijs, Paco M J Welsing, Marlies C van der Goes, Johannes WG Jacobs, Désirée van der Heijde, Jacob M van Laar, György Nagy

doi: 10.1136/annrheumdis-2020-219535

December 03, 2020

Correspondence response
Response to: ‘Correspondence on ‘Prevotella copri in individuals at risk for rheumatoid arthritis’’ by Sun and Ni
Free

Benoît Thomas P Gilbert, Axel Finckh, Deshire Alpizar Rodriguez

doi: 10.1136/annrheumdis-2020-219365
Correspondence
Correspondence on ‘Prevotella copri in individuals at risk for rheumatoid arthritis’
Free

Tianyue Sun, Jing Ni

doi: 10.1136/annrheumdis-2020-219347

November 12, 2020

Correspondence
Correspondence on ‘Impact of COVID-19 pandemic on patients with large-vessels vasculitis in Italy: a monocentric survey’
Free

Cloé Comarmond, Mathilde Leclercq, Gaëlle Leroux, Cindy Marques, Alexandre Le Joncour, Fanny Domont, Céline Hatte, Ségolène Toquet-Bouedec, Perrine Guillaume-Jugnot, Anne-Claire Desbois, Mathieu Vautier, Aude Rigolet, Yves Allenbach, Olivier Benveniste, David Saadoun, Patrice Cacoub

doi: 10.1136/annrheumdis-2020-219407
Correspondence response
Response to: ‘Correspondence on ‘Impact of COVID-19 pandemic on patients with large-vessels vasculitis in Italy: a monocentric survey’ by Comarmond et al
Free

Alessandro Tomelleri, Silvia Sartorelli, Elena Marina Baldissera, Lorenzo Dagna, Corrado Campochiaro

doi: 10.1136/annrheumdis-2020-219414

November 11, 2020

Correspondence
Correspondence to ‘Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study’
Free

Wenjie Zheng, Pui-Ying Leong, James Cheng-Chung Wei

doi: 10.1136/annrheumdis-2020-218865
Correspondence response
Response to ‘Correspondence on ‘Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study’’ by Zheng et al
Free

Dimitrios A Pappas, Gregory St John, Carol J Etzel, Stefano Fiore, Taylor Blachley, Toshio Kimura, Rajeshwari Punekar, Kelechi Emeanuru, Jeannie Choi, Susan Boklage, Joel M Kremer

doi: 10.1136/annrheumdis-2020-218907
Correspondence response
Response to ‘Correspondence on ‘Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort’ by Ruyssen-Witrand et al
Free

Adrian Ciurea, Axel Finckh

doi: 10.1136/annrheumdis-2020-219420

November 10, 2020

Correspondence response
Response to ‘Correspondence on ‘Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis’’ by Shi et al
Free

Shintaro Akiyama, Shadi Hamdeh, Dejan Micic, Atsushi Sakuraba

doi: 10.1136/annrheumdis-2020-219394
Correspondence
Correspondence on ‘prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis’
Free

Jiyuan Shi, Ya Gao, Lili Zhang, Yang Zhao, Jianguo Xu, Jinhui Tian

doi: 10.1136/annrheumdis-2020-219377

November 06, 2020

Correspondence response
Response to: ‘Correspondence on ‘Machine learning integration of scleroderma histology and gene expression identifies fibroblast polarisation as a hallmark of clinical severity and improvement’’ by Manetti
Free

Kimberly Showalter, Cynthia Magro, Yaxia Zhang, Robert Spiera, Dana E Orange, Jessica K Gordon

doi: 10.1136/annrheumdis-2020-219292
Correspondence
Correspondence on ‘Tapering towards DMARD-free remission in rheumatoid arthritis’
Free

Iveth Eunice García, Carlos Abud-Mendoza

doi: 10.1136/annrheumdis-2020-219239
Correspondence response
Response to: ‘Correspondence on ‘Tapering towards DMARD-free remission in rheumatoid arthritis’ by Garcia et al
Free

Elise van Mulligen, Pascal Hendrik Pieter de Jong

doi: 10.1136/annrheumdis-2020-219293
Correspondence
Correspondence on ‘Machine learning integration of scleroderma histology and gene expression identifies fibroblast polarisation as a hallmark of clinical severity and improvement’
Free

Mirko Manetti

doi: 10.1136/annrheumdis-2020-219264

November 04, 2020

Correspondence
Correspondence on ‘The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease’
Free

Rory James Redmond Peters, Harry Martin, Aleena Virdee, Eve Fryer, Helen Bungay, Manuel Rodriguez-Justo, Manil Chouhan, Eleanor Barnes, George Webster, Emma L Culver

doi: 10.1136/annrheumdis-2020-218894

November 03, 2020

Correspondence
Correspondence on ‘Systemic evaluation of the relationship between psoriasis, psoriatic arthritis and osteoporosis: observational and Mendelian randomisation study’
Free

Ran Cui, Qiang Tong, Zhi-Yong Chen, Miao Chen, Sheng-Ming Dai

doi: 10.1136/annrheumdis-2020-219173
Correspondence response
Response to: ‘Correspondence on ‘Systemic evaluation of the relationship between psoriasis, psoriatic arthritis and osteoporosis: observational and Mendelian randomisation study’’ by Cui et al
Free

Ke-Qi Liu, Jiangwei Xia, Qiu-Ping Chen, Jian-Qiang Yang, Hou-Feng Zheng

doi: 10.1136/annrheumdis-2020-219183
Correspondence response
Response to: ‘Correspondence on ‘Gender disparity in authorship of guidelines and recommendations in rheumatology’’ by Stewart et al
Free

Giovanni Adami, Camilla Benini, Elisabetta Vantaggiato, Denise Rotta, Ombretta Viapiana, Davide Gatti, Maurizio Rossini, Annamaria Iagnocco

doi: 10.1136/annrheumdis-2020-219305
Correspondence response
Response to ‘Correspondence on ‘Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis’’ by Gremese et al
Free

Shintaro Akiyama, Shadi Hamdeh, Dejan Micic, Atsushi Sakuraba

doi: 10.1136/annrheumdis-2020-219337
Correspondence
Correspondence on ‘Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis’
Free

Elisa Gremese, Giovanni Brondani, Luca Apollonio, Gianfranco Ferraccioli

doi: 10.1136/annrheumdis-2020-219309
Correspondence
Correspondence on ‘Increased risk of systemic lupus erythematosus in patients with autoimmune haemolytic anaemia’
Free

Hong Huang, Zhuoli Zhang

doi: 10.1136/annrheumdis-2020-219257
Correspondence
Correspondence on ‘Gender disparity in authorship of guidelines and recommendations in rheumatology’
Free

Sarah Stewart, Elizaveta Rakhmanova, Nicola Dalbeth

doi: 10.1136/annrheumdis-2020-219220
Correspondence
Correspondence on ‘The use of tocilizumab and tofacitinib in patients with resolved hepatitis B infection: a case series’
Free

Ryu Watanabe, Motomu Hashimoto, Akio Morinobu

doi: 10.1136/annrheumdis-2020-219270
Correspondence response
Response to: ‘Correspondence on ‘Increased risk of systemic lupus erythematosus in patients with autoimmune haemolytic anaemia’’ by Huang and Zhang
Free

Han-You Mo, James Cheng Chung Wei, Xiao-Huan Chen, Hsin-Hua Chen

doi: 10.1136/annrheumdis-2020-219269

November 02, 2020

Correspondence
Correspondence on ‘Impact of rheumatoid arthritis on major cardiovascular events in patients with and without coronary artery disease’
Free

Gwo-Ping Jong, Lung-Fa Pan, Tsung-Kun Lin, Hung-Yi Chen

doi: 10.1136/annrheumdis-2020-219201
Correspondence response
Response to ‘Correspondence on ‘Impact of rheumatoid arthritis on major cardiovascular events in patients with and without coronary artery disease” by Jong et al
Free

Brian Bridal Løgstrup, Kevin Kris Warnakula Olesen, Dzenan Masic, Christine Gyldenkerne, Pernille Gro Thrane, Torkell Ellingsen, Hans Erik Bøtker, Michael Maeng

doi: 10.1136/annrheumdis-2020-219231

October 30, 2020

Correspondence response
Response to ‘Neither earlier not late tocilizumab improved outcomes in the intensive care unit patients with COVID-19 in a retrospective cohort study’ by Moiseev et al
Free

Sofia Ramiro, Robert B M Landewé, Rémy Mostard

doi: 10.1136/annrheumdis-2020-219295
Correspondence
Neither earlier nor late tocilizumab improved outcomes in the intensive care unit patients with COVID-19 in a retrospective cohort study
Free

Sergey Moiseev, Sergey Avdeev, Ekaterina Tao, Michail Brovko, Nikolay Bulanov, Anastasiia Zykova, Larisa Akulkina, Irina Smirnova, Victor Fomin

doi: 10.1136/annrheumdis-2020-219265
Correspondence response
Response to: ‘Correspondence on ‘Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases’’ by Schulze-Koops et al
Free

Dalifer Dayanira Freites Nuñez, Leticia Leon, Arkaitz Mucientes, Luis Rodriguez-Rodriguez, Judit Font Urgelles, Alfredo Madrid García, Jose Ignacio Colomer, Juan A Jover, Benjamín Fernandez-Gutierrez, Lydia Abasolo

doi: 10.1136/annrheumdis-2020-219230
Correspondence
Correspondence to ‘Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases’
Free

Hendrik Schulze-Koops, Alla Skapenko, Andreas Krause, Klaus Krueger, Hanns-Martin Lorenz, Philipp Sewerin, Christof Specker, Ulf G Wagner, Anna Voormann, Ulf Mueller-Ladner, Reinhard E Voll

doi: 10.1136/annrheumdis-2020-218997

October 20, 2020

Correspondence
Correspondence on ‘2018 update of the EULAR recommendations for the management of hand osteoarthritis’
Free

Young Sun Suh, Hyun-Ok Kim, Chang Han Lee, Chul Ho Yoon, Yun-Hong Cheon, Mingyo Kim, Hanna Lee, Sang-Il Lee

doi: 10.1136/annrheumdis-2020-218887

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online First

December 16, 2020

December 14, 2020

December 11, 2020

December 09, 2020

December 04, 2020

December 03, 2020

December 02, 2020

November 25, 2020

November 20, 2020

November 12, 2020

November 11, 2020

November 10, 2020

November 06, 2020

November 04, 2020

November 03, 2020

November 02, 2020

October 30, 2020

October 20, 2020

Pages